Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology

Tiny Jaarsma; Loreena Hill; Antoni Bayes-Genis; Hans-Peter Brunner-La Rocca; Teresa Castiello; Jelena Celutkiene; Elena Marques-Sule; Carla M. Plymen; Susan E. Piper; Barbara Riegel; Frans H. Rutten; Tuvia Ben Gal; Johann Bauersachs; Andrew J. S. Coats; Ovidiu Chioncel; Yuri Lopatin; Lars H. Lund; Mitja Lainscak; Brenda Moura; Wilfried Mullens; Massimo F. Piepoli; Giuseppe Rosano; Petar Seferovic; Anna Stromberg

doi:10.1002/ejhf.2008

Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology

Tiny Jaarsma^*, Loreena Hill, Antoni Bayes-Genis, Hans-Peter Brunner-La Rocca, Teresa Castiello, Jelena Celutkiene, Elena Marques-Sule, Carla M. Plymen, Susan E. Piper, Barbara Riegel, Frans H. Rutten, Tuvia Ben Gal, Johann Bauersachs, Andrew J. S. Coats, Ovidiu Chioncel, Yuri Lopatin, Lars H. Lund, Mitja Lainscak, Brenda Moura, Wilfried MullensMassimo F. Piepoli, Giuseppe Rosano, Petar Seferovic, Anna Stromberg

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Self-care is essential in the long-term management of chronic heart failure. Heart failure guidelines stress the importance of patient education on treatment adherence, lifestyle changes, symptom monitoring and adequate response to possible deterioration. Self-care is related to medical and person-centred outcomes in patients with heart failure such as better quality of life as well as lower mortality and readmission rates. Although guidelines give general direction for self-care advice, health care professionals working with patients with heart failure need more specific recommendations. The aim of the management recommendations in this paper is to provide practical advice for health professionals delivering care to patients with heart failure. Recommendations for nutrition, physical activity, medication adherence, psychological status, sleep, leisure and travel, smoking, immunization and preventing infections, symptom monitoring, and symptom management are consistent with information from guidelines, expert consensus documents, recent evidence and expert opinion.

Original language	English
Pages (from-to)	157-174
Number of pages	18
Journal	European journal of heart failure
Volume	23
Issue number	1
Early online date	20 Oct 2020
DOIs	https://doi.org/10.1002/ejhf.2008
Publication status	Published - Jan 2021

Keywords

Self-care
Heart failure
Lifestyle
Patient education
REDUCED EJECTION FRACTION
2013 ACCF/AHA GUIDELINE
QUALITY-OF-LIFE
AMERICAN-COLLEGE
TASK-FORCE
CARDIOVASCULAR-DISEASES
VENTRICULAR DYSFUNCTION
EXERCISE CAPACITY
AIR-TRAVEL
MEDICATION

Access to Document

10.1002/ejhf.2008Licence: CC BY-NC

Cite this

Jaarsma, T., Hill, L., Bayes-Genis, A., Brunner-La Rocca, H.-P., Castiello, T., Celutkiene, J., Marques-Sule, E., Plymen, C. M., Piper, S. E., Riegel, B., Rutten, F. H., Ben Gal, T., Bauersachs, J., Coats, A. J. S., Chioncel, O., Lopatin, Y., Lund, L. H., Lainscak, M., Moura, B., ... Stromberg, A. (2021). Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology. European journal of heart failure, 23(1), 157-174. https://doi.org/10.1002/ejhf.2008

@article{c7f150f40c974f438dfc9a877eca6a66,

title = "Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology",

abstract = "Self-care is essential in the long-term management of chronic heart failure. Heart failure guidelines stress the importance of patient education on treatment adherence, lifestyle changes, symptom monitoring and adequate response to possible deterioration. Self-care is related to medical and person-centred outcomes in patients with heart failure such as better quality of life as well as lower mortality and readmission rates. Although guidelines give general direction for self-care advice, health care professionals working with patients with heart failure need more specific recommendations. The aim of the management recommendations in this paper is to provide practical advice for health professionals delivering care to patients with heart failure. Recommendations for nutrition, physical activity, medication adherence, psychological status, sleep, leisure and travel, smoking, immunization and preventing infections, symptom monitoring, and symptom management are consistent with information from guidelines, expert consensus documents, recent evidence and expert opinion.",

keywords = "Self-care, Heart failure, Lifestyle, Patient education, REDUCED EJECTION FRACTION, 2013 ACCF/AHA GUIDELINE, QUALITY-OF-LIFE, AMERICAN-COLLEGE, TASK-FORCE, CARDIOVASCULAR-DISEASES, VENTRICULAR DYSFUNCTION, EXERCISE CAPACITY, AIR-TRAVEL, MEDICATION",

author = "Tiny Jaarsma and Loreena Hill and Antoni Bayes-Genis and {Brunner-La Rocca}, Hans-Peter and Teresa Castiello and Jelena Celutkiene and Elena Marques-Sule and Plymen, {Carla M.} and Piper, {Susan E.} and Barbara Riegel and Rutten, {Frans H.} and {Ben Gal}, Tuvia and Johann Bauersachs and Coats, {Andrew J. S.} and Ovidiu Chioncel and Yuri Lopatin and Lund, {Lars H.} and Mitja Lainscak and Brenda Moura and Wilfried Mullens and Piepoli, {Massimo F.} and Giuseppe Rosano and Petar Seferovic and Anna Stromberg",

note = "Funding Information: : L.H. reports personal fees from Novartis, outside the submitted work. A.B.G. reports personal fees from Abbott, Novartis, Vifor Pharma, during the conduct of the study; grants from Roche Diagnostics, personal fees from Critical Diagnostics, AstraZeneca, outside the submitted work. H.P.B.L.R. reports grants and personal fees from Vifor Pharma, Novartis. J.C. reports personal fees from Novartis, Servier, Grindex, Boehringer Ingelheim, AstraZeneca; grants from Roche Diagnostics, outside the submitted work. C.M.P. reports personal fees from Novartis, Vifor Pharma, outside the submitted work. S.E.P. reports personal fees from Novartis, AstraZeneca, Vifor Pharma, outside the submitted work. J.B. reports personal fees from Novartis, BMS, Pfizer, Bayer, Servier, MSD, Boehringer Ingelheim, AstraZeneca, Abbott, Medtronic, Daichii Sankyo; grants and personal fees from Vifor, CvRX, Abiomed, Zoll, outside the submitted work. A.J.S.C. reports personal fees from AstraZeneca, Bayer, Boehringer Ingelhiem, Menarini, Novartis, Nutricia, Servier, Vifor, Actimed, Arena, Cardiac Dimensions, Corvia, CVRx, Enopace, ESN Cleer, Faraday, Gore, Impulse Dynamics, Respicardia, outside the submitted work. O.C. reports grants from Servier, Novartis, Vifor, other from Boehringer, outside the submitted work. L.H.L. reports personal fees from Merck, Sanofi, Bayer, Pharmacosmos, Abbott, Medscape, Myokardia; grants and personal fees from Vifor‐Fresenius, AstraZeneca, Relypsa, Novartis, Mundipharma, Boehringer Ingelheim; grants from Boston Scientific, outside the submitted work. M.L. reports personal fees from Vifor‐Fresenius, AstraZeneca, Relypsa, Bayer, Novartis, Boehringer Ingelheim, outside the submitted work. The other authors have nothing to disclose. Conflict of interest Funding Information: We would like to thank Richard Mindham, member of the ESC Patient Forum for his comments and suggestions for this paper. Conflict of interest: L.H. reports personal fees from Novartis, outside the submitted work. A.B.G. reports personal fees from Abbott, Novartis, Vifor Pharma, during the conduct of the study; grants from Roche Diagnostics, personal fees from Critical Diagnostics, AstraZeneca, outside the submitted work. H.P.B.L.R. reports grants and personal fees from Vifor Pharma, Novartis. J.C. reports personal fees from Novartis, Servier, Grindex, Boehringer Ingelheim, AstraZeneca; grants from Roche Diagnostics, outside the submitted work. C.M.P. reports personal fees from Novartis, Vifor Pharma, outside the submitted work. S.E.P. reports personal fees from Novartis, AstraZeneca, Vifor Pharma, outside the submitted work. J.B. reports personal fees from Novartis, BMS, Pfizer, Bayer, Servier, MSD, Boehringer Ingelheim, AstraZeneca, Abbott, Medtronic, Daichii Sankyo; grants and personal fees from Vifor, CvRX, Abiomed, Zoll, outside the submitted work. A.J.S.C. reports personal fees from AstraZeneca, Bayer, Boehringer Ingelhiem, Menarini, Novartis, Nutricia, Servier, Vifor, Actimed, Arena, Cardiac Dimensions, Corvia, CVRx, Enopace, ESN Cleer, Faraday, Gore, Impulse Dynamics, Respicardia, outside the submitted work. O.C. reports grants from Servier, Novartis, Vifor, other from Boehringer, outside the submitted work. L.H.L. reports personal fees from Merck, Sanofi, Bayer, Pharmacosmos, Abbott, Medscape, Myokardia; grants and personal fees from Vifor-Fresenius, AstraZeneca, Relypsa, Novartis, Mundipharma, Boehringer Ingelheim; grants from Boston Scientific, outside the submitted work. M.L. reports personal fees from Vifor-Fresenius, AstraZeneca, Relypsa, Bayer, Novartis, Boehringer Ingelheim, outside the submitted work. The other authors have nothing to disclose. Publisher Copyright: {\textcopyright} 2020 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.",

year = "2021",

month = jan,

doi = "10.1002/ejhf.2008",

language = "English",

volume = "23",

pages = "157--174",

journal = "European journal of heart failure",

issn = "1388-9842",

publisher = "Wiley",

number = "1",

}

Jaarsma, T, Hill, L, Bayes-Genis, A, Brunner-La Rocca, H-P, Castiello, T, Celutkiene, J, Marques-Sule, E, Plymen, CM, Piper, SE, Riegel, B, Rutten, FH, Ben Gal, T, Bauersachs, J, Coats, AJS, Chioncel, O, Lopatin, Y, Lund, LH, Lainscak, M, Moura, B, Mullens, W, Piepoli, MF, Rosano, G, Seferovic, P & Stromberg, A 2021, 'Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology', European journal of heart failure, vol. 23, no. 1, pp. 157-174. https://doi.org/10.1002/ejhf.2008

TY - JOUR

T1 - Self-care of heart failure patients

T2 - practical management recommendations from the Heart Failure Association of the European Society of Cardiology

AU - Jaarsma, Tiny

AU - Hill, Loreena

AU - Bayes-Genis, Antoni

AU - Brunner-La Rocca, Hans-Peter

AU - Castiello, Teresa

AU - Celutkiene, Jelena

AU - Marques-Sule, Elena

AU - Plymen, Carla M.

AU - Piper, Susan E.

AU - Riegel, Barbara

AU - Rutten, Frans H.

AU - Ben Gal, Tuvia

AU - Bauersachs, Johann

AU - Coats, Andrew J. S.

AU - Chioncel, Ovidiu

AU - Lopatin, Yuri

AU - Lund, Lars H.

AU - Lainscak, Mitja

AU - Moura, Brenda

AU - Mullens, Wilfried

AU - Piepoli, Massimo F.

AU - Rosano, Giuseppe

AU - Seferovic, Petar

AU - Stromberg, Anna

N1 - Funding Information: : L.H. reports personal fees from Novartis, outside the submitted work. A.B.G. reports personal fees from Abbott, Novartis, Vifor Pharma, during the conduct of the study; grants from Roche Diagnostics, personal fees from Critical Diagnostics, AstraZeneca, outside the submitted work. H.P.B.L.R. reports grants and personal fees from Vifor Pharma, Novartis. J.C. reports personal fees from Novartis, Servier, Grindex, Boehringer Ingelheim, AstraZeneca; grants from Roche Diagnostics, outside the submitted work. C.M.P. reports personal fees from Novartis, Vifor Pharma, outside the submitted work. S.E.P. reports personal fees from Novartis, AstraZeneca, Vifor Pharma, outside the submitted work. J.B. reports personal fees from Novartis, BMS, Pfizer, Bayer, Servier, MSD, Boehringer Ingelheim, AstraZeneca, Abbott, Medtronic, Daichii Sankyo; grants and personal fees from Vifor, CvRX, Abiomed, Zoll, outside the submitted work. A.J.S.C. reports personal fees from AstraZeneca, Bayer, Boehringer Ingelhiem, Menarini, Novartis, Nutricia, Servier, Vifor, Actimed, Arena, Cardiac Dimensions, Corvia, CVRx, Enopace, ESN Cleer, Faraday, Gore, Impulse Dynamics, Respicardia, outside the submitted work. O.C. reports grants from Servier, Novartis, Vifor, other from Boehringer, outside the submitted work. L.H.L. reports personal fees from Merck, Sanofi, Bayer, Pharmacosmos, Abbott, Medscape, Myokardia; grants and personal fees from Vifor‐Fresenius, AstraZeneca, Relypsa, Novartis, Mundipharma, Boehringer Ingelheim; grants from Boston Scientific, outside the submitted work. M.L. reports personal fees from Vifor‐Fresenius, AstraZeneca, Relypsa, Bayer, Novartis, Boehringer Ingelheim, outside the submitted work. The other authors have nothing to disclose. Conflict of interest Funding Information: We would like to thank Richard Mindham, member of the ESC Patient Forum for his comments and suggestions for this paper. Conflict of interest: L.H. reports personal fees from Novartis, outside the submitted work. A.B.G. reports personal fees from Abbott, Novartis, Vifor Pharma, during the conduct of the study; grants from Roche Diagnostics, personal fees from Critical Diagnostics, AstraZeneca, outside the submitted work. H.P.B.L.R. reports grants and personal fees from Vifor Pharma, Novartis. J.C. reports personal fees from Novartis, Servier, Grindex, Boehringer Ingelheim, AstraZeneca; grants from Roche Diagnostics, outside the submitted work. C.M.P. reports personal fees from Novartis, Vifor Pharma, outside the submitted work. S.E.P. reports personal fees from Novartis, AstraZeneca, Vifor Pharma, outside the submitted work. J.B. reports personal fees from Novartis, BMS, Pfizer, Bayer, Servier, MSD, Boehringer Ingelheim, AstraZeneca, Abbott, Medtronic, Daichii Sankyo; grants and personal fees from Vifor, CvRX, Abiomed, Zoll, outside the submitted work. A.J.S.C. reports personal fees from AstraZeneca, Bayer, Boehringer Ingelhiem, Menarini, Novartis, Nutricia, Servier, Vifor, Actimed, Arena, Cardiac Dimensions, Corvia, CVRx, Enopace, ESN Cleer, Faraday, Gore, Impulse Dynamics, Respicardia, outside the submitted work. O.C. reports grants from Servier, Novartis, Vifor, other from Boehringer, outside the submitted work. L.H.L. reports personal fees from Merck, Sanofi, Bayer, Pharmacosmos, Abbott, Medscape, Myokardia; grants and personal fees from Vifor-Fresenius, AstraZeneca, Relypsa, Novartis, Mundipharma, Boehringer Ingelheim; grants from Boston Scientific, outside the submitted work. M.L. reports personal fees from Vifor-Fresenius, AstraZeneca, Relypsa, Bayer, Novartis, Boehringer Ingelheim, outside the submitted work. The other authors have nothing to disclose. Publisher Copyright: © 2020 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

PY - 2021/1

Y1 - 2021/1

N2 - Self-care is essential in the long-term management of chronic heart failure. Heart failure guidelines stress the importance of patient education on treatment adherence, lifestyle changes, symptom monitoring and adequate response to possible deterioration. Self-care is related to medical and person-centred outcomes in patients with heart failure such as better quality of life as well as lower mortality and readmission rates. Although guidelines give general direction for self-care advice, health care professionals working with patients with heart failure need more specific recommendations. The aim of the management recommendations in this paper is to provide practical advice for health professionals delivering care to patients with heart failure. Recommendations for nutrition, physical activity, medication adherence, psychological status, sleep, leisure and travel, smoking, immunization and preventing infections, symptom monitoring, and symptom management are consistent with information from guidelines, expert consensus documents, recent evidence and expert opinion.

AB - Self-care is essential in the long-term management of chronic heart failure. Heart failure guidelines stress the importance of patient education on treatment adherence, lifestyle changes, symptom monitoring and adequate response to possible deterioration. Self-care is related to medical and person-centred outcomes in patients with heart failure such as better quality of life as well as lower mortality and readmission rates. Although guidelines give general direction for self-care advice, health care professionals working with patients with heart failure need more specific recommendations. The aim of the management recommendations in this paper is to provide practical advice for health professionals delivering care to patients with heart failure. Recommendations for nutrition, physical activity, medication adherence, psychological status, sleep, leisure and travel, smoking, immunization and preventing infections, symptom monitoring, and symptom management are consistent with information from guidelines, expert consensus documents, recent evidence and expert opinion.

KW - Self-care

KW - Heart failure

KW - Lifestyle

KW - Patient education

KW - REDUCED EJECTION FRACTION

KW - 2013 ACCF/AHA GUIDELINE

KW - QUALITY-OF-LIFE

KW - AMERICAN-COLLEGE

KW - TASK-FORCE

KW - CARDIOVASCULAR-DISEASES

KW - VENTRICULAR DYSFUNCTION

KW - EXERCISE CAPACITY

KW - AIR-TRAVEL

KW - MEDICATION

U2 - 10.1002/ejhf.2008

DO - 10.1002/ejhf.2008

M3 - Article

C2 - 32945600

SN - 1388-9842

VL - 23

SP - 157

EP - 174

JO - European journal of heart failure

JF - European journal of heart failure

IS - 1

ER -